316 related articles for article (PubMed ID: 31392668)
1. The Effect of Type 2 Diabetes on Bone Biomechanics.
Karim L; Rezaee T; Vaidya R
Curr Osteoporos Rep; 2019 Oct; 17(5):291-300. PubMed ID: 31392668
[TBL] [Abstract][Full Text] [Related]
2. Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes.
Karim L; Moulton J; Van Vliet M; Velie K; Robbins A; Malekipour F; Abdeen A; Ayres D; Bouxsein ML
Bone; 2018 Sep; 114():32-39. PubMed ID: 29857063
[TBL] [Abstract][Full Text] [Related]
3. Induction and rescue of skeletal fragility in a high-fat diet mouse model of type 2 diabetes: An in vivo and in vitro approach.
LLabre JE; Sroga GE; Tice MJL; Vashishth D
Bone; 2022 Mar; 156():116302. PubMed ID: 34952229
[TBL] [Abstract][Full Text] [Related]
4. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.
Karim L; Bouxsein ML
Bone; 2016 Jan; 82():21-7. PubMed ID: 26211993
[TBL] [Abstract][Full Text] [Related]
5. Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel.
Chiodini I; Gaudio A; Palermo A; Napoli N; Vescini F; Falchetti A; Merlotti D; Eller-Vainicher C; Carnevale V; Scillitani A; Pugliese G; Rendina D; Salcuni A; Bertoldo F; Gonnelli S; Nuti R; Toscano V; Triggiani V; Cenci S; Gennari L
Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2210-2233. PubMed ID: 34059385
[TBL] [Abstract][Full Text] [Related]
6. Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength.
Yamamoto M
Endocr J; 2015; 62(4):299-308. PubMed ID: 25797364
[TBL] [Abstract][Full Text] [Related]
7. Are diabetes microvascular complications risk factors for fragility fracture?
Almutlaq N; Neyman A; DiMeglio LA
Curr Opin Endocrinol Diabetes Obes; 2021 Aug; 28(4):354-359. PubMed ID: 33989258
[TBL] [Abstract][Full Text] [Related]
8. Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes.
Piccoli A; Cannata F; Strollo R; Pedone C; Leanza G; Russo F; Greto V; Isgrò C; Quattrocchi CC; Massaroni C; Silvestri S; Vadalà G; Bisogno T; Denaro V; Pozzilli P; Tang SY; Silva MJ; Conte C; Papalia R; Maccarrone M; Napoli N
J Bone Miner Res; 2020 Dec; 35(12):2415-2422. PubMed ID: 32777114
[TBL] [Abstract][Full Text] [Related]
9. Skeletal fragility in diabetes.
Rubin MR
Ann N Y Acad Sci; 2017 Aug; 1402(1):18-30. PubMed ID: 28926113
[TBL] [Abstract][Full Text] [Related]
10. Contributors to impaired bone health in type 2 diabetes.
Sheu A; Greenfield JR; White CP; Center JR
Trends Endocrinol Metab; 2023 Jan; 34(1):34-48. PubMed ID: 36435679
[TBL] [Abstract][Full Text] [Related]
11. Assessment and treatment of osteoporosis and fractures in type 2 diabetes.
Sheu A; Greenfield JR; White CP; Center JR
Trends Endocrinol Metab; 2022 May; 33(5):333-344. PubMed ID: 35307247
[TBL] [Abstract][Full Text] [Related]
12. Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism.
Lee HS; Hwang JS
Curr Diab Rep; 2020 Nov; 20(12):78. PubMed ID: 33247351
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility.
Eller-Vainicher C; Cairoli E; Grassi G; Grassi F; Catalano A; Merlotti D; Falchetti A; Gaudio A; Chiodini I; Gennari L
J Diabetes Res; 2020; 2020():7608964. PubMed ID: 32566682
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and Deficits in Cortical Bone Density, Microarchitecture, and Bone Size: Framingham HR-pQCT Study.
Samelson EJ; Demissie S; Cupples LA; Zhang X; Xu H; Liu CT; Boyd SK; McLean RR; Broe KE; Kiel DP; Bouxsein ML
J Bone Miner Res; 2018 Jan; 33(1):54-62. PubMed ID: 28929525
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus.
Botushanov NP; Orbetzova MM
Folia Med (Plovdiv); 2009; 51(4):12-7. PubMed ID: 20232652
[TBL] [Abstract][Full Text] [Related]
16. Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes.
Sellmeyer DE; Civitelli R; Hofbauer LC; Khosla S; Lecka-Czernik B; Schwartz AV
Diabetes; 2016 Jul; 65(7):1757-66. PubMed ID: 27329951
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation endproducts and bone quality: practical implications for people with type 2 diabetes.
Moseley KF; Du Z; Sacher SE; Ferguson VL; Donnelly E
Curr Opin Endocrinol Diabetes Obes; 2021 Aug; 28(4):360-370. PubMed ID: 34183538
[TBL] [Abstract][Full Text] [Related]
18. Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus.
Khosla S; Samakkarnthai P; Monroe DG; Farr JN
Nat Rev Endocrinol; 2021 Nov; 17(11):685-697. PubMed ID: 34518671
[TBL] [Abstract][Full Text] [Related]
19. Prediabetes and skeletal health.
Lindsay C; Shieh A
Curr Opin Endocrinol Diabetes Obes; 2023 Aug; 30(4):200-205. PubMed ID: 37248797
[TBL] [Abstract][Full Text] [Related]
20. [Increased fracture rate in patients with type 2 diabetes mellitus is independent of its bone mineral density].
Yamamoto M; Yamaguchi T; Sugimoto T
Clin Calcium; 2006 Aug; 16(8):1308-14. PubMed ID: 16883038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
